Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Sovaldi/Harvoni

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Sovaldi/Harvoni was produced by Gilead Sciences.

Gilead must pay just $200m for hep C patents, says jury

Gilead must pay just $200m for hep C patents, says jury Merck &Co awarded a 4% royalty rate on sales of Sovaldi and Harvoni. ... Merck had been pushing for a 10% royalty rate on the $20.7bn Gilead had made from sales of two sofosbuvir-based drugs - Sovaldi and Harvoni - between 2013 and 2015, after

Merck & Co wins hepatitis C patent dispute with Gilead

Merck & Co wins hepatitis C patent dispute with Gilead The jury in the lawsuit upheld Merck's claim that Gilead's sofosbuvir - which features in its massive-selling Sovaldi and Harvoni HCV drugs - infringes two patents it holds alongside Ionis ... The consequences of the ruling remain unclear but in

Priority FDA review for new Gilead HCV combination therapy

Priority FDA review for new Gilead HCV combination therapy months. Sovaldi broke all records for a new pharmaceutical launch when it reached the market - racking up $10bn in sales in 2014 (its first full year on the market). ... It has since fallen back as treatment has switched to Harvoni, with sales of the

Access to new hep C treatments put under the spotlight

Access to new hep C treatments put under the spotlight And a month later NICE also recommended NHS funding for Gilead's next-gen version of Sovaldi, Harvoni (ledipasvir-sofosbuvir), which can cure up to 99% of all patients in eight ... Harvoni costs slightly more than Sovaldi per patient (at £39, 000, but

NHS England sets up new £190m hep C fund

NHS England sets up new £190m hep C fund to AbbVie's Viekirax, a three-drug combination therapy for the disease, and Exviera (dasabuvir), as well as Gilead's hep C pills Sovaldi and Harvoni. ... Recent documents from NHS England seen by PMLiVE however showed that if Sovaldi and Harvoni were

[ Previous 5 results ] 1 2 3 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....